Michael Weiser is listed as an executive officer and director on 10 SEC Form D filings by 3 issuers between Sep 2009 and Jul 2016: ZIOPHARM ONCOLOGY INC (Boston, MA — biotechnology — 2009–2016; $120M reported sold to 26 investors), EMISPHERE TECHNOLOGIES INC (Roseland, NJ — pharmaceuticals — 2010–2013; $35.2M reported sold to 16 investors) and Foresight Biotherapeutics, Inc. (New York, NY — biotechnology — 2011–2013; $15M reported sold to 2 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $170.2M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 10 public filings for Michael Weiser and found 6 differences: Industry group changed between filings; Same name, different state: "Michael Weiser" (CA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.